LSL Pharma Group Inc. (TSXV:LSL)

Canada · Delayed Price · Currency is CAD

0.4100

+0.0150 (3.80%)

At close: Apr 10, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Oct '20 Oct 3, 2020
Vitamins & Nutrition Products	17.75M	10.03M	8.21M	8.77M	10.05M
Vitamins & Nutrition Products Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%
Total	17.75M	10.03M	8.21M	8.77M	10.05M
Total Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Oct '20 Oct 3, 2020
Canada	17.75M	10.03M	8.21M	8.77M	10.05M
Canada Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%
Total	17.75M	10.03M	8.21M	8.77M	10.05M
Total Growth	76.98%	22.08%	-6.35%	-12.70%	108.32%

Source: S&P Global Market Intelligence.